Oncostatin M and its receptor are markers of endoscopic and histological disease activity in Inflammatory Bowel Disease

被引:0
|
作者
Nguyen, A. [1 ,2 ,3 ]
Sturm, G. [4 ]
Plattner, C. [4 ]
Trajanoski, Z. [4 ]
Atreya, R. [5 ]
Siegmund, B. [2 ,3 ]
Hegazy, A. N. [2 ,3 ,6 ,7 ]
机构
[1] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia
[2] Charite Univ Med Berlin, Berlin, Germany
[3] Humboldt Univ, Med Dept Gastroenterol Infectiol & Rheumatol, Berlin, Germany
[4] Med Univ Innsbruck, Bioctr, Inst Bioinformat, Innsbruck, Austria
[5] Friedrich Alexander Univ, Univ Klinikum Erlangen, Med Klin 1, Erlangen, Germany
[6] BIH, Berlin, Germany
[7] German Rheumatism Res Ctr DRFZ, Inflammatory Mech, Berlin, Germany
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
P247
引用
收藏
页码:I397 / I398
页数:2
相关论文
共 50 条
  • [21] Implementation of screening criteria for inflammatory bowel disease in patients with spondyloarthritis and its association with disease and endoscopic activity
    Jaiber Gutiérrez-Sánchez
    Viviana Parra-Izquierdo
    Cristian Flórez-Sarmiento
    Diego Alejandro Jaimes
    Juliette De Ávila
    Juan Manuel Bello-Gualtero
    Alejandro Ramos-Casallas
    Lorena Chila-Moreno
    César Pacheco-Tena
    Adriana Beltrán-Ostos
    Philippe Chalem-Choueka
    Wilson Bautista-Molano
    Consuelo Romero-Sánchez
    Clinical Rheumatology, 2023, 42 : 415 - 422
  • [22] UTILITY OF INFLAMMATORY MARKERS IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASE AND THEIR CORRELATION WITH DISEASE ACTIVITY INDICES
    Toke, Nilesh
    Ramaswamy, Pradeep
    Panackel, Charles
    Sebastian, Benoy
    Mathai, Sunil
    GUT, 2019, 68 : A122 - A122
  • [23] Relation Between Endoscopic and Histological Activity of the Intestinal Inflammatory Bowel Disease (IBD) and Angiogenic and Lymphangiogenic Factors
    Algaba, Alicia
    Linares, Pablo M.
    Contreras, Maria Encarnacion Fernandez
    Ordonez, Amparo
    Porrero, Javier Trapaga
    Guerta, Ivan
    Chaparro, Maria
    Agullo, Jose Luis Rodriguez
    Gisbert, Javier P.
    Bermejo, Fernando
    GASTROENTEROLOGY, 2011, 140 (05) : S843 - S843
  • [24] Relationship between histological and endoscopic activity and angiogenic and lymphangiogenic factors expression in patients with inflammatory bowel disease
    Linares, P. M.
    Chaparro, M.
    Algaba, A.
    Guerra, I.
    Bermejo, F.
    Gisbert, J. P.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S89 - S89
  • [25] Oncostatin M as a new diagnostic, prognostic and therapeutic target in inflammatory bowel disease (IBD)
    Verstockt, Sare
    Verstockt, Bram
    Vermeire, Severine
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (11) : 943 - 954
  • [26] Histological controversies in inflammatory bowel disease
    Haboubi, N
    8TH BIENNIAL CONGRESS OF THE EUROPEAN COUNCIL OF COLOPROCTOLOGY (ECCP), 2001, : 183 - 185
  • [27] Histological scores in inflammatory bowel disease
    Neri, Benedetto
    Mossa, Michelangela
    Scucchi, Ludovica
    Sena, Giorgia
    Palmieri, Giampiero
    Biancone, Livia
    JOURNAL OF DIGESTIVE DISEASES, 2021, 22 (01) : 9 - 22
  • [28] Serologic disease markers in inflammatory bowel disease
    Morral, ED
    MEDICINA CLINICA, 2004, 122 (04): : 138 - 139
  • [29] Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease
    Kamp, Kendra J.
    Clark-Snustad, Kindra
    Barahimi, Mitra
    Lee, Scott
    GASTROENTEROLOGY NURSING, 2022, 45 (01) : 21 - 28
  • [30] Molecular Simulation of Oncostatin M and Receptor (OSM-OSMR) Interaction as a Potential Therapeutic Target for Inflammatory Bowel Disease
    Du, Qingqing
    Qian, Yan
    Xue, Weiwei
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7